Director · Mineralys Therapeutics, Inc. · Common Stock
Side
SELL
Value
$3.01M
Shares
104.3K
Price
$28.81
Executed
Sep 22, 2026
Disclosed
Sep 24, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 22 executedSep 24, 2026 disclosed
MLYS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Slingsby Brian Taylor filed this Form 4 reporting a open-market sale of MLYS on Sep 22, 2026. It became public on Sep 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Slingsby Brian Taylorcik:0001963901
Issuer
Mineralys Therapeutics, Inc.cik:0001933414
Revision history · 0
No field has changed since this record was first ingested.
